Clinical Trial Update: Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders [NA]

View source ↗

Summary

A completed clinical trial evaluating a conditioning regimen of fludarabine phosphate, melphalan, total-body irradiation, and donor stem cell transplantation fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Marrow Failure Disorders
• Hematologic Cancer

Drugs mentioned

• Fludarabine phosphate, melphalan, total-body irradiation, donor stem cell transplant

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome | NA | Status: COMPLETED | Results posted: 2016-06-13